Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.
MRI
brain metastases
imaging
protocol
Journal
Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420
Informations de publication
Date de publication:
09 06 2020
09 06 2020
Historique:
pubmed:
13
2
2020
medline:
28
4
2021
entrez:
13
2
2020
Statut:
ppublish
Résumé
A recent meeting was held on March 22, 2019, among the FDA, clinical scientists, pharmaceutical and biotech companies, clinical trials cooperative groups, and patient advocacy groups to discuss challenges and potential solutions for increasing development of therapeutics for central nervous system metastases. A key issue identified at this meeting was the need for consistent tumor measurement for reliable tumor response assessment, including the first step of standardized image acquisition with an MRI protocol that could be implemented in multicenter studies aimed at testing new therapeutics. This document builds upon previous consensus recommendations for a standardized brain tumor imaging protocol (BTIP) in high-grade gliomas and defines a protocol for brain metastases (BTIP-BM) that addresses unique challenges associated with assessment of CNS metastases. The "minimum standard" recommended pulse sequences include: (i) parameter matched pre- and post-contrast inversion recovery (IR)-prepared, isotropic 3D T1-weighted gradient echo (IR-GRE); (ii) axial 2D T2-weighted turbo spin echo acquired after injection of gadolinium-based contrast agent and before post-contrast 3D T1-weighted images; (iii) axial 2D or 3D T2-weighted fluid attenuated inversion recovery; (iv) axial 2D, 3-directional diffusion-weighted images; and (v) post-contrast 2D T1-weighted spin echo images for increased lesion conspicuity. Recommended sequence parameters are provided for both 1.5T and 3T MR systems. An "ideal" protocol is also provided, which replaces IR-GRE with 3D TSE T1-weighted imaging pre- and post-gadolinium, and is best performed at 3T, for which dynamic susceptibility contrast perfusion is included. Recommended perfusion parameters are given.
Identifiants
pubmed: 32048719
pii: 5734626
doi: 10.1093/neuonc/noaa030
pmc: PMC7283031
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
757-772Subventions
Organisme : NCI NIH HHS
ID : P30 CA014236
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
NMR Biomed. 2013 Aug;26(8):913-31
pubmed: 22782914
AJNR Am J Neuroradiol. 1992 Jul-Aug;13(4):1221-4
pubmed: 1636540
AJNR Am J Neuroradiol. 2019 Sep;40(9):1469-1475
pubmed: 31371358
J Nucl Med. 2014 Jan;55(1):30-6
pubmed: 24167081
Neuroradiology. 2014 Jun;56(6):437-43
pubmed: 24652530
J Magn Reson Imaging. 2014 Apr;39(4):745-67
pubmed: 24399498
Neuro Oncol. 2018 Mar 27;20(4):567-575
pubmed: 29016814
JAMA Oncol. 2017 Jun 1;3(6):827-831
pubmed: 27892978
AJNR Am J Neuroradiol. 1994 Jun;15(6):1053-61
pubmed: 8073973
Cancer. 1978 Aug;42(2):660-8
pubmed: 679158
J Neurosurg. 2016 Feb;124(2):489-95
pubmed: 26361281
J Neurosurg. 2015 Aug;123(2):373-86
pubmed: 25978710
AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98
pubmed: 26185325
Quant Imaging Med Surg. 2013 Jun;3(3):141-6
pubmed: 23833727
Eur Radiol. 1997;7 Suppl 5:276-80
pubmed: 9370559
Lancet Oncol. 2013 Sep;14(10):e396-406
pubmed: 23993384
AJNR Am J Neuroradiol. 2009 May;30(5):923-9
pubmed: 19213825
AJR Am J Roentgenol. 2018 Jul;211(1):168-175
pubmed: 29708785
Lancet Oncol. 2015 Nov;16(15):e534-e542
pubmed: 26545842
Neuro Oncol. 2017 Feb 1;19(2):281-288
pubmed: 27471107
J Med Imaging Radiat Oncol. 2009 Aug;53(4):366-72
pubmed: 19695043
Radiology. 1987 Dec;165(3):609-17
pubmed: 3317495
Anticancer Res. 2008 Jan-Feb;28(1B):407-13
pubmed: 18383877
Clin Exp Metastasis. 2016 Mar;33(3):277-84
pubmed: 26786978
Neuro Oncol. 2015 Mar;17(3):457-65
pubmed: 25452395
Neuro Oncol. 2015 Sep;17(9):1188-98
pubmed: 26250565
JAMA. 2016 Jul 26;316(4):401-409
pubmed: 27458945
Handb Clin Neurol. 2018;149:89-112
pubmed: 29307364
J Neurosurg. 2004 May;100(5):835-41
pubmed: 15137602
AJNR Am J Neuroradiol. 2018 Feb;39(2):280-288
pubmed: 29242363
J Neurooncol. 2010 Aug;99(1):81-8
pubmed: 20058049
Magn Reson Med Sci. 2008;7(1):13-21
pubmed: 18460844
AJNR Am J Neuroradiol. 2018 Jun;39(6):1025-1031
pubmed: 29724761
J Magn Reson Imaging. 1992 Jan-Feb;2(1):9-18
pubmed: 1623287
AJNR Am J Neuroradiol. 2019 Mar;40(3):412-417
pubmed: 30733252
Radiology. 1993 Mar;186(3):855-60
pubmed: 8430199
AJNR Am J Neuroradiol. 1996 Nov-Dec;17(10):1853-9
pubmed: 8933869
AJNR Am J Neuroradiol. 2011 Apr;32(4):664-70
pubmed: 21292797
Neuro Oncol. 2019 May 6;21(5):585-595
pubmed: 30615138
Acta Radiol. 1995 May;36(3):300-6
pubmed: 7742127
Cancer. 2008 Apr 15;112(8):1827-34
pubmed: 18311784
Ann Oncol. 2018 Nov 1;29(11):2214-2222
pubmed: 30215676
Neuroradiology. 1997 Jul;39(7):483-9
pubmed: 9258924
Curr Treat Options Neurol. 2008 Jul;10(4):308-14
pubmed: 18579017
AJNR Am J Neuroradiol. 1992 Jul-Aug;13(4):1199-206
pubmed: 1636537
Magn Reson Imaging. 1997;15(5):535-41
pubmed: 9253997
Acta Radiol. 2009 Oct;50(8):933-40
pubmed: 19626475
Neurology. 1977 Jul;27(7):650-5
pubmed: 559971
Eur Radiol. 2011 Mar;21(3):449-56
pubmed: 21181406
Neuro Oncol. 2016 Oct;18(10):1462-4
pubmed: 27591333
Magn Reson Med. 1991 Dec;22(2):249-54; discussion 265-7
pubmed: 1812354
Neuroradiology. 2015 Apr;57(4):367-76
pubmed: 25592446
AJNR Am J Neuroradiol. 2018 Aug;39(8):1453-1459
pubmed: 30002052
Neuro Oncol. 2017 Apr 1;19(4):586-594
pubmed: 27634933
Invest Radiol. 2012 Feb;47(2):136-41
pubmed: 22104961
Acta Neurochir Suppl. 2013;116:193-210
pubmed: 23417479
Acta Radiol. 2008 Dec;49(10):1167-73
pubmed: 18979271
Lung Cancer. 2004 Dec;46(3):357-60
pubmed: 15541821
AJR Am J Roentgenol. 2011 Sep;197(3):697-703
pubmed: 21862814
Invest Radiol. 2010 Jan;45(1):49-56
pubmed: 19996757
J Clin Oncol. 2012 Feb 1;30(4):419-25
pubmed: 22203767
AJNR Am J Neuroradiol. 2019 Apr;40(4):626-633
pubmed: 30923088
Korean J Radiol. 2014 Jan-Feb;15(1):145-50
pubmed: 24497805
JAMA Oncol. 2018 Jul 1;4(7):1001-1003
pubmed: 29799956
J Neurooncol. 2016 Dec;130(3):485-494
pubmed: 27568036
AJNR Am J Neuroradiol. 1994 Jan;15(1):37-44
pubmed: 8141064
J Neurooncol. 2016 Sep;129(2):363-71
pubmed: 27324495
Neuroimage Clin. 2018 Aug 19;20:537-542
pubmed: 30175040
AJNR Am J Neuroradiol. 2003 Apr;24(4):648-51
pubmed: 12695197
J Neurooncol. 2014 Apr;117(2):303-10
pubmed: 24504499
J Neurooncol. 1999;44(3):275-81
pubmed: 10720207
Stroke. 2002 Jul;33(7):1799-802
pubmed: 12105356
AJNR Am J Neuroradiol. 1991 Mar-Apr;12(2):293-300
pubmed: 1902031
J Neurosurg. 2016 Jul;125(1):17-23
pubmed: 26544782
AJR Am J Roentgenol. 2019 Feb;212(2):425-430
pubmed: 30422717
AJNR Am J Neuroradiol. 2017 Aug;38(8):1520-1527
pubmed: 28619837
Invest Radiol. 2011 Jul;46(7):411-8
pubmed: 21467949
Invest Radiol. 2002 Mar;37(3):114-9
pubmed: 11882790
AJNR Am J Neuroradiol. 2018 Sep;39(9):1635-1642
pubmed: 30093483
Neurosurgery. 2008 Nov;63(5):898-903; discussion 904
pubmed: 19005380
Neuro Oncol. 2017 Apr 1;19(4):484-492
pubmed: 28039364
Curr Oncol Rep. 2012 Feb;14(1):48-54
pubmed: 22012633
J Comput Assist Tomogr. 2016 Sep-Oct;40(5):803-5
pubmed: 27636126
Arch Neurol. 1988 Jul;45(7):741-4
pubmed: 3390029
J Clin Oncol. 2019 May 1;37(13):1081-1089
pubmed: 30860945
Surg Neurol Int. 2013 May 02;4(Suppl 4):S192-202
pubmed: 23717790
Neuro Oncol. 2017 Oct 1;19(10):1391-1397
pubmed: 28472527
Lancet Oncol. 2013 Sep;14(10):e407-16
pubmed: 23993385
J Radiat Res. 2013 Jan;54(1):135-9
pubmed: 22843378
J Neurooncol. 2005 Oct;75(1):15-20
pubmed: 16215812
Eur J Radiol. 2013 Jan;82(1):139-45
pubmed: 21890295
AJNR Am J Neuroradiol. 2018 Nov;39(11):1981-1988
pubmed: 30309842
AJNR Am J Neuroradiol. 1994 Jun;15(6):1037-51
pubmed: 8073972
Invest Radiol. 2013 Jan;48(1):55-60
pubmed: 23192164
AJNR Am J Neuroradiol. 2019 Jul;40(7):1140-1148
pubmed: 31221635
J Neurosurg. 2006 Dec;105 Suppl:175-82
pubmed: 18503353
J Neurooncol. 2005 Oct;75(1):31-42
pubmed: 16215814
Cancer. 2007 Jan 1;109(1):135-45
pubmed: 17133440
AJNR Am J Neuroradiol. 2015 Dec;36(12):2250-5
pubmed: 26427832
Invest Radiol. 2003 Jul;38(7):415-22
pubmed: 12821855
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1236-1243
pubmed: 30353872
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1446-1457
pubmed: 31865407
AJNR Am J Neuroradiol. 2006 Aug;27(7):1419-25
pubmed: 16908550
AJNR Am J Neuroradiol. 2010 Jun;31(6):1055-8
pubmed: 20110372
Cancer. 1996 Oct 15;78(8):1781-8
pubmed: 8859192
AJR Am J Roentgenol. 2018 Dec;211(6):1332-1341
pubmed: 30240297
Neuro Oncol. 2019 May 6;21(5):648-658
pubmed: 30715514
AJNR Am J Neuroradiol. 2009 Feb;30(2):367-72
pubmed: 19022867
Neurosurg Clin N Am. 2011 Jan;22(1):15-25, v
pubmed: 21109145
Radiology. 2015 Jun;275(3):772-82
pubmed: 25742194
Neuro Oncol. 2012 Sep;14(9):1171-7
pubmed: 22898372
Eur J Neurol. 2006 Jul;13(7):674-81
pubmed: 16834697
Mayo Clin Proc. 1994 Nov;69(11):1062-8
pubmed: 7967760
Lancet Oncol. 2015 Jun;16(6):e270-8
pubmed: 26065612
AJNR Am J Neuroradiol. 1990 Jul-Aug;11(4):785-91
pubmed: 2114769
Lancet Oncol. 2017 Aug;18(8):1049-1060
pubmed: 28687377
Neuro Oncol. 2017 Apr 1;19(suppl_2):ii2-ii15
pubmed: 28380635
AJR Am J Roentgenol. 2012 Jul;199(1):W17-23
pubmed: 22733927
Magn Reson Med. 2015 Dec;74(6):1780-9
pubmed: 25426597
Radiology. 1987 Dec;165(3):619-24
pubmed: 3317496
J Nucl Med. 2012 Sep;53(9):1367-74
pubmed: 22872742
Anticancer Res. 2012 Nov;32(11):4655-62
pubmed: 23155227
J Clin Oncol. 2004 Jul 15;22(14):2865-72
pubmed: 15254054
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):277-90, v
pubmed: 17893049
AJNR Am J Neuroradiol. 1992 Jan-Feb;13(1):335-45
pubmed: 1595472
J Neurooncol. 2012 Aug;109(1):149-58
pubmed: 22638727
Eur J Surg Oncol. 2017 Mar;43(3):604-611
pubmed: 27769635
AJNR Am J Neuroradiol. 2010 May;31(5):868-73
pubmed: 20037130
J Neurooncol. 2015 Oct;125(1):149-56
pubmed: 26307446
AJNR Am J Neuroradiol. 1998 May;19(5):821-8
pubmed: 9613494
Eur Radiol. 2016 Jun;26(6):1818-25
pubmed: 26334511
Lancet Oncol. 2018 Dec;19(12):1654-1667
pubmed: 30413378
J Neurooncol. 1997 Oct;35(1):81-9
pubmed: 9266444
Magn Reson Med Sci. 2016;15(1):34-40
pubmed: 26104076
J Neurooncol. 2014 Jun;118(2):351-361
pubmed: 24760414
J Neurol. 2009 Jun;256(6):878-87
pubmed: 19274425
Lancet Oncol. 2018 May;19(5):672-681
pubmed: 29602646
Eur J Radiol. 2008 Sep;67(3):415-26
pubmed: 18455895
Lancet Neurol. 2005 May;4(5):289-98
pubmed: 15847842
AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):1885-92
pubmed: 21920854
Eur Radiol. 2007 Sep;17(9):2345-51
pubmed: 17318603
PLoS One. 2012;7(12):e52008
pubmed: 23251672
AJNR Am J Neuroradiol. 2017 Mar;38(3):478-484
pubmed: 28034995
Neuro Oncol. 2016 Aug;18(8):1043-65
pubmed: 27382120
Magn Reson Med. 1991 Dec;22(2):358-63
pubmed: 1812371
Neurol Med Chir (Tokyo). 2009 Sep;49(9):394-401
pubmed: 19779283
AJNR Am J Neuroradiol. 1994 Jan;15(1):155-9
pubmed: 8141048
J Comput Assist Tomogr. 2008 Mar-Apr;32(2):313-9
pubmed: 18379324
AJNR Am J Neuroradiol. 1995 Feb;16(2):373-80
pubmed: 7726087
N Engl J Med. 2018 Aug 23;379(8):722-730
pubmed: 30134131
Neuro Oncol. 2013 Dec;15(12):1732-8
pubmed: 24243914